- KR₩51bn
- KR₩74bn
- KR₩107bn
- 68
- 70
- 28
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | 0.73 | ||
| Price to Free Cashflow | 10 | ||
| Price to Sales | 0.5 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.74% | ||
| Return on Equity | -9.59% | ||
| Operating Margin | -12.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 61,688.01 | 74,290.41 | 82,604.11 | 97,897.44 | 106,981.86 | n/a | n/a | 10.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -22.72 | +40.97 | -1.22 | -7.76 | -42.39 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Genoray Co Ltd is a Korea-based company principally engaged in the manufacture and sale of X-ray imaging diagnostic equipment. The Company is principally engaged in the manufacture and sale of X-ray imaging diagnostic equipment used to diagnose patients in medical environments such as hospitals and dental clinics. The Company’s products include C-arm, mammography equipment, computed tomography (CT) equipment as well as others.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- April 12th, 2001
- Public Since
- May 28th, 2018
- No. of Shareholders
- 7,244
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 12,147,346
- Address
- 60, SEONGNAM, 13212
- Web
- https://www.genoray.com
- Phone
- +82 3151785500
- Auditors
- Shinhan Accounting Corporation
Upcoming Events for 122310
Genoray Co Ltd Annual Shareholders Meeting
Similar to 122310
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alpha AI Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
What is the Genoray Co share price?
As of Today at 19:48 UTC, shares in Genoray Co are trading at KR₩4,235. This share price information is delayed by 15 minutes.
How has the Genoray Co share price performed this year?
Shares in Genoray Co last closed at KR₩4,235 and the price had moved by -26.18% over the past 365 days. In terms of relative price strength the Genoray Co share price has underperformed the FTSE Developed Asia Pacific Index by -48.06% over the past year.
What are the analyst and broker recommendations for Genoray Co?
The overall consensus recommendation for Genoray Co is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Genoray Co dividend yield?
The Genoray Co dividend yield is 4.25% based on the trailing twelve month period.
Does Genoray Co pay a dividend?
Last year, Genoray Co paid a total dividend of KR₩180, and it currently has a trailing dividend yield of 4.25%.Looking ahead, shares in Genoray Co are due to go ex-dividend on 2026-02-26 and the next dividend pay date is 2026-04-23.
When does Genoray Co next pay dividends?
Genoray Co are due to go ex-dividend on 2026-02-26 and the next dividend pay date is 2026-04-23. The historic dividend yield on Genoray Co shares is currently 4.25%.
How do I buy Genoray Co shares?
To buy shares in Genoray Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Genoray Co?
As of the previous close price of KR₩4,235, shares in Genoray Co had a market capitalisation of KR₩51bn.
Where are Genoray Co shares listed?
Here are the trading details for Genoray Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 122310
What kind of share is Genoray Co?
Based on an overall assessment of its quality, value and momentum Genoray Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Genoray Co share price forecast for 2026?
The analyst consensus target price for shares in Genoray Co is KR₩15,500. That is 266% above the last closing price of KR₩4,235.
Analysts covering Genoray Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Genoray Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genoray Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -39.75%.
As of the last closing price of KR₩4,235, shares in Genoray Co were trading -17.98% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Genoray Co PE Ratio?
The Genoray Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩4,235.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Genoray Co?
Genoray Co's management team is headed by:
- Byeong Wuk Park - CEO